Protein arginine deiminase 4 (PAD4) is a transcriptional coregulator that catalyzes the calcium-dependent conversion of specific arginine residues in proteins to citrulline. Recently, we reported the synthesis and characterization of F-amidine, a potent and bioavailable irreversible inactivator of PAD4. Herein, we report our efforts to identify the steric and leaving group requirements for F-amidine-induced PAD4 inactivation, the structure of the PAD4-F-amidine x calcium complex, and in vivo studies with N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide (Cl-amidine), a PAD4 inactivator with enhanced potency. The PAD4 inactivators described herein will be useful pharmacological probes in characterizing the incompletely defined phy...
The protein arginine deiminases (PADs), which catalyze the hydrolysis of peptidyl-arginine to form p...
Protein Arginine Deiminase IV (PAD4) is a new target for rheumatoid arthritis (RA) therapeutic. It c...
The protein arginine deiminases (PADs), and in particular PAD4, have emerged as potential therapeuti...
Protein arginine deiminase 4 (PAD4) is a calcium-dependent transcriptional corepressor that has been...
The family of Protein Arginine Deiminases (PADs) include five mammalian isozymes (PAD1, 2, 3, 4, and...
Protein citrullination has been shown to regulate numerous physiological pathways (e.g., the innate ...
Protein arginine deiminase activity (PAD) is increased in cancer, rheumatoid arthritis, and ulcerati...
Dysregulated protein arginine deiminase (PAD) activity, particularly PAD4, has been suggested to pla...
Protein arginine deiminase activity (PAD) is increased in cancer, rheumatoid arthritis, and ulcerati...
Protein arginine deiminase 4 (PAD4) is an enzyme that hydrolyzes peptidyl arginine residues to form ...
The presumed role of an overactive protein arginine deiminase 4 (PAD4) in the pathophysiology of rhe...
Protein arginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes the conversion of a...
Citrullination, a posttranslational modification, is catalyzed by peptidylarginine deiminases (PADs)...
Citrullination, a posttranslational modification, is catalyzed by peptidylarginine deiminases (PADs)...
Protein arginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes the conversion of a...
The protein arginine deiminases (PADs), which catalyze the hydrolysis of peptidyl-arginine to form p...
Protein Arginine Deiminase IV (PAD4) is a new target for rheumatoid arthritis (RA) therapeutic. It c...
The protein arginine deiminases (PADs), and in particular PAD4, have emerged as potential therapeuti...
Protein arginine deiminase 4 (PAD4) is a calcium-dependent transcriptional corepressor that has been...
The family of Protein Arginine Deiminases (PADs) include five mammalian isozymes (PAD1, 2, 3, 4, and...
Protein citrullination has been shown to regulate numerous physiological pathways (e.g., the innate ...
Protein arginine deiminase activity (PAD) is increased in cancer, rheumatoid arthritis, and ulcerati...
Dysregulated protein arginine deiminase (PAD) activity, particularly PAD4, has been suggested to pla...
Protein arginine deiminase activity (PAD) is increased in cancer, rheumatoid arthritis, and ulcerati...
Protein arginine deiminase 4 (PAD4) is an enzyme that hydrolyzes peptidyl arginine residues to form ...
The presumed role of an overactive protein arginine deiminase 4 (PAD4) in the pathophysiology of rhe...
Protein arginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes the conversion of a...
Citrullination, a posttranslational modification, is catalyzed by peptidylarginine deiminases (PADs)...
Citrullination, a posttranslational modification, is catalyzed by peptidylarginine deiminases (PADs)...
Protein arginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes the conversion of a...
The protein arginine deiminases (PADs), which catalyze the hydrolysis of peptidyl-arginine to form p...
Protein Arginine Deiminase IV (PAD4) is a new target for rheumatoid arthritis (RA) therapeutic. It c...
The protein arginine deiminases (PADs), and in particular PAD4, have emerged as potential therapeuti...